| Title | Description | ||||
|---|---|---|---|---|---|
| Active Ingredients |
|
||||
| Dosage Form | CAPSULE, EXTENDED RELEASE | ||||
| Packaging | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-0913-1), 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-0913-2), 180 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-0913-3), 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-0913-4), 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-0913-5), 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-0913-6), 270 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-0913-7), | ||||
| Pharm Type | Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE] |